Rational design of potent human transthyretin amyloid disease inhibitors.
Klabunde, T., Petrassi, H.M., Oza, V.B., Raman, P., Kelly, J.W., Sacchettini, J.C.(2000) Nat.Struct.Mol.Biol. 7: 312-321
- PubMed: 10742177 
- DOI: 10.1038/74082
- Primary Citation of Related Structures:  
- PubMed Abstract: 
The human amyloid disorders, familial amyloid polyneuropathy, familial amyloid cardiomyopathy and senile systemic amyloidosis, are caused by insoluble transthyretin (TTR) fibrils, which deposit in the peripheral nerves and heart tissue. Several nonst ...